Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.77 |
| ▸ | HPGD | P15428 | 3/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.77 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.66 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.66 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.66 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.66 |
| ▸ | CA12 | O43570 | 2/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | CA7 | P43166 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.57 |
| ▸ | CA3 | P07451 | 1/20 | 0.57 |
| ▸ | CA4 | P22748 | 1/20 | 0.57 |
| ▸ | CA6 | P23280 | 1/20 | 0.57 |
| ▸ | CA5A | P35218 | 1/20 | 0.57 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL164671 | 0.89 | ALDH1A1 (0.84) | KDM4EALDH1A1HPGDHSD17B10GRIN2D | |
| SCHEMBL29450082 | 0.89 | ALDH1A1 (0.84) | KDM4EALDH1A1HPGDHSD17B10GRIN2D | |
| SCHEMBL551105 | 0.87 | ALDH1A1 (1.00) | KDM4EALDH1A1HPGDHSD17B10GRIN2D | |
| SCHEMBL29353299 | 0.87 | ALDH1A1 (1.00) | KDM4EALDH1A1HPGDHSD17B10GRIN2D | |
| SCHEMBL5344077 | 0.86 | KDM4E (0.61) | KDM4EALDH1A1HPGDHSD17B10GRIN2D | |
| SCHEMBL10390227 | 0.85 | GRIN2D (0.62) | KDM4EALDH1A1HPGDHSD17B10GRIN2D | |
| SCHEMBL8126323 | 0.84 | ALDH1A1 (0.88) | KDM4EALDH1A1HPGDHSD17B10GRIN2D | |
| SCHEMBL12521444 | 0.82 | KMT2A (0.62) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| SCHEMBL24895096 | 0.81 | KDM4E (0.59) | KDM4EALDH1A1HPGDHSD17B10GRIN2D | |
| SCHEMBL29620158 | 0.81 | ALDH1A1 (0.77) | KDM4EALDH1A1HPGDHSD17B10GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0836592-A1 | AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 1998-04-22 | — | — | EP | claimed |
| WO-1997002249-A1 | NOVEL AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 1997-01-23 | — | — | WO | claimed |
| US-4948582-A | PRETREATMENT WITH AN OXYNAPHTHOIC ACID DERIVATIVE | RORER PHARMACEUTICAL CORPORATION (US) | 1990-08-14 | — | — | US | claimed |
| EP-0347932-A2 | Treatment of conditions requiring enhanced oxygen availability to mammalian tissues | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-12-27 | — | — | EP | claimed |
| US-4861795-A | USING NAPHTHOIC ACID DERIVATIVE | RORER PHARMACEUTICAL CORPORATION (US) | 1989-08-29 | — | — | US | claimed |
| US-6136969-A | PROTEIN KINASE INHIBITORS; 4-HYDROXYBENZOIC ACID 3-(4-(4-FLUOROBENZOYLOXY)-BENZOYLAMINO)-AZEPAN-4-YL ESTER | HOFFMANN-LA ROCHE INC. (US) | 2000-10-24 | — | — | US | disclosed |
| US-5907038-A | PROTEIN KINASE INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 1999-05-25 | — | — | US | disclosed |
| US-5830920-A | PREVENTION GROWTH OF SMOOTH MUSCLE CELLS | HOFFMANN-LA ROCHE INC. (US) | 1998-11-03 | — | — | US | disclosed |
| EP-0836592-A1 | AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 1998-04-22 | — | — | EP | disclosed |
| WO-1997002249-A1 | NOVEL AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 1997-01-23 | — | — | WO | disclosed |
| EP-0347932-A2 | Treatment of conditions requiring enhanced oxygen availability to mammalian tissues | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-12-27 | — | — | EP | disclosed |
| US-4861795-A | USING NAPHTHOIC ACID DERIVATIVE | RORER PHARMACEUTICAL CORPORATION (US) | 1989-08-29 | — | — | US | disclosed |